[Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
Rorive
G
G
Université de Liège, CHU, Service de Néphrologie.
Creytens
G
G
Ruhwiedel
M
M
Van de Voorde
K
K
D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007211:Indoles / Q000009:adverse effects / Q000633:toxicity*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020913:Perindopril
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007211:Indoles; D001262:Atenolol; D020913:Perindopril
Etude comparative de l'efficacité et de la tolérance du périndopril, un nouvel inhibiteur de l'enzyme de conversion, et de l'aténolol, un bêta-bloquant.